Medicus Pharma Ltd. (MDCX) Financial Statements
Industry: Pharmaceutical Preparations
In fiscal 2025, Medicus Pharma reported revenue of $0. Net income was -$47.3M, or -$137.00 per diluted share. Operating activities generated -$22.8M of cash. At fiscal year end, Medicus Pharma held $10.1M in total assets against $10.0M in total liabilities, including $8.7M of cash and equivalents.
Open the full interactive Medicus Pharma financials → Quarterly statements, key ratios, valuation history and price charts.
Medicus Pharma Key Stats
| Share Price | $3.28 |
|---|---|
| Market Cap | $3.6M |
| 52-Week Range | $0.16 – $8.55 |
| Shares Outstanding | 1.1 million (basic, 2026 Q2) |
Medicus Pharma Income Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Revenue | $0 | $0 |
| Operating Income | -$11.2M | -$34.4M |
| Pre-Tax Income | -$11.2M | -$47.3M |
| Income Tax | $0 | $0 |
| Net Income | -$11.2M | -$47.3M |
| Diluted EPS | -$58.00 | -$137.00 |
Medicus Pharma Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net Income | -$20.9M | -$15.1M | -$9.0M | -$11.6M |
| Diluted EPS | -$56.00 | -$0.87 | -$15.50 | -$10.50 |
Medicus Pharma Balance Sheet
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash & Equivalents | $4.2M | $8.7M |
| Current Assets | $5.4M | $9.9M |
| Total Assets | $5.6M | $10.1M |
| Current Liabilities | $2.3M | $9.9M |
| Total Long-Term Debt | — | $25,865 |
| Total Liabilities | $2.5M | $10.0M |
| Shareholders' Equity | $3.1M | -$67,554 |
Medicus Pharma Cash Flow Statement
| FY 2024 | FY 2025 | |
|---|---|---|
| Cash From Operations | -$10.2M | -$22.8M |
| Cash From Investing | — | -$4.6M |
| Cash From Financing | $12.7M | $31.9M |
Figures from Medicus Pharma's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Medicus Pharma financials page for every line item.
Medicus Pharma Company Profile
| Ticker | MDCX |
|---|---|
| Exchange | Nasdaq |
| Industry | Pharmaceutical Preparations |
| Headquarters | W. Conshohocken, Pennsylvania |
| Fiscal Year End | December 31 |
| SEC Filer Category | Emerging growth company |
| SEC CIK | 0001997296 |
Frequently Asked Questions
What was Medicus Pharma's revenue in fiscal 2025?
Medicus Pharma (MDCX) reported revenue of $0 for fiscal 2025.
What was Medicus Pharma's net income in fiscal 2025?
Medicus Pharma reported net income of -$47.3M for fiscal 2025.
What was Medicus Pharma's earnings per share (EPS) in fiscal 2025?
Medicus Pharma's diluted EPS was -$137.00 for fiscal 2025 (adjusted for any later stock splits).
What was Medicus Pharma's revenue last quarter?
In its most recent reported quarter (2026 Q2), Medicus Pharma reported revenue of $0.
How much debt does Medicus Pharma have?
Medicus Pharma reported $25,865 of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Medicus Pharma are outstanding?
Medicus Pharma reported a weighted average of 1.1 million basic shares outstanding in 2026 Q2.
What is Medicus Pharma's market cap?
Based on its latest closing price, Medicus Pharma (MDCX) has a market capitalization of about $3.6M.
When does Medicus Pharma's fiscal year end?
Medicus Pharma's fiscal year end, as registered with the SEC, is December 31.
Where is Medicus Pharma headquartered?
Medicus Pharma lists its business address in W. Conshohocken, Pennsylvania in its SEC filings.